1-4 of 4
Christine Bieri, MBA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Resource Utilizers From The Multicenter Compact Study Of Complications In Patients With Sickle Cell Disease and Utilization Of Iron Chelation Therapy

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia A Oneal, MD, Medha Sasane, BPharm, PhD, Francis Vekeman, MA, Christine Bieri, MBA, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Abigail Adams, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2013) 122 (21): 982.
https://doi.org/10.1182/blood.V122.21.982.982
Published: 2013
Journal Articles

Final Results From the Multicenter Compact Study of Complications in Patients with Sickle Cell Disease and Utilization of Iron Chelation Therapy: A Retrospective Medical Records Review.

Lanetta B Jordan, MD, MPH, MSPH, Patricia Adams-Graves, MD, Julie Kanter-Washko, MD, Patricia Ann Oneal, MD, Francis Vekeman, MA, Christine Bieri, MBA, Medha Sasane, BPharm, PhD, Andrea Marcellari, MS, MT(ASCP), Matthew Magestro, MBA, MS, Zachary Gorn, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2012) 120 (21): 2106.
https://doi.org/10.1182/blood.V120.21.2106.2106
Published: 2012
Journal Articles

Dynamics of Improvement in Health-Related Quality of Life (HRQoL) with Long-Term Eltrombopag Treatment in Adults with Chronic Immune Thrombocytopenia (ITP) in EXTEND.

Kelly M Grotzinger, James B Bussel, MD, Mansoor N Saleh, MD, Christine Bieri, MBA, Yuliya Orlova, Andres Brainsky, MD
Journal: Blood
Blood (2012) 120 (21): 2199.
https://doi.org/10.1182/blood.V120.21.2199.2199
Published: 2012
Journal Articles

Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or —Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck Emmanuel Nicolini, MD, PhD, Dong-Wook Kim, MD, PhD, Bernadeta Ceglarek, Anna Turkina, Giuliana Alimena, Haifa Kathrin Al-Ali, MD, Zhixiang Shen, Saengsuree Jootar, MD, Graeme Smith, MD, Carmino Antonio De Souza, MD, PhD, Pedro Enrique Dorlhiac-Llacer, David A. Rizzieri, MD, Tomasz Szczudlo, MD, Myriam Berton, Jim Wang, PhD, Christine Bieri, MBA, Philipp D. le Coutre, MD
Journal: Blood
Blood (2009) 114 (22): 2201.
https://doi.org/10.1182/blood.V114.22.2201.2201
Published: 2009